Inventor · disambiguated record
Xiawei Wei
Also filed as: WEI XIAWEI
10 granted patents·8 pending applications·5 citations·filing 2016–2024
79Inventor score
Files withJUMBO DRUG BANK CO LTD5WESTGENE BIOPHARMA CO LTD4WESTVAC BIOPHARMA CO LTD3MEDSHINE DISCOVERY INC2SHENZHEN OPTIMUM BIOLOGICAL TECH CO LTD2
Top patents by PatentIndex Score
18 records- 0184US11839657B2Ionizable lipids and compositions for nucleic acid deliveryWESTGENE BIOPHARMA CO LTD·Filed 2023·Granted Dec 12, 2023·1 cites·24 claims
- 0280US11136315B2CXCR2 antagonistMEDSHINE DISCOVERY INC·Filed 2019·Granted Oct 5, 2021·2 cites·18 claims
- 0377US11738072B2Tumor vaccine and uses thereofWESTVAC BIOPHARMA CO LTD·Filed 2018·Granted Aug 29, 2023·2 cites·39 claims
- 0473US12440569B2Ionizable lipids and compositions for nucleic acid deliveryWESTGENE BIOPHARMA CO LTD·Filed 2023·Granted Oct 14, 2025·0 cites·19 claims
- 0560US2025000959A1Nucleic acid molecules, fusion proteins, and mrna vaccines with enhanced antigen presentation by recruiting ligandsWESTGENE BIOPHARMA CO LTD·Filed 2024·Application pending·0 cites
- 0659US2025134813A1Compounds, lipsomes, and drug carriers for drug deliveryWESTGENE BIOPHARMA CO LTD·Filed 2023·Application pending·0 cites
- 0758US2024207390A1Rhabdovirus-negative spodoptera frugiperda insect cell line, and screening, identification and application thereofWESTVAC BIOPHARMA CO LTD·Filed 2022·Application pending·0 cites
- 0857US2025188077A1Crystal form of 1h-pyrrolo[2,3-c]pyridine compound and preparation method thereforJUMBO DRUG BANK CO LTD·Filed 2023·Application pending·0 cites
- 0955US12492215B2Pyrrolotriazine compounds acting as MNK inhibitorJUMBO DRUG BANK CO LTD·Filed 2022·Granted Dec 9, 2025·0 cites·20 claims
- 1055US10869922B2Alhydrogel-sodium chloride compound immunologic adjuvant, preparation method and use thereofUNIV SICHUAN·Filed 2016·Granted Dec 22, 2020·0 cites·16 claims
- 1153US2024254144A1Salt form of pyrrolotriazine compound, crystal form thereof, and preparation method thereforJUMBO DRUG BANK CO LTD·Filed 2022·Application pending·0 cites
- 1252US12310948B2Application of monocyclic β-lactam compound in pharmacySHENZHEN OPTIMUM BIOLOGICAL TECH CO LTD·Filed 2019·Granted May 27, 2025·0 cites·19 claims
- 1351US11739090B2Substituted pyrazlo[3,4-c]pyridines as selective BTK kinase inhibitorsJUMBO DRUG BANK CO LTD·Filed 2020·Granted Aug 29, 2023·0 cites·16 claims
- 1450US12491180B2Application of compound in treating pneumoniaSHENZHEN OPTIMUM BIOLOGICAL TECH CO LTD·Filed 2020·Granted Dec 9, 2025·0 cites·17 claims
- 1549US2024182466A1A Crystal Form of a Fluorine-substituted Pyridopyrazole Compound and a Preparation Method ThereofJUMBO DRUG BANK CO LTD·Filed 2022·Application pending·0 cites
- 1642US2023233665A1Anti- sars-cov-2-infection protein and vaccineWESTVAC BIOPHARMA CO LTD·Filed 2020·Application pending·0 cites
- 1740US2021078958A1Quinazoline derivative and use thereofMEDSHINE DISCOVERY INC·Filed 2018·Application pending·0 cites
- 1836US11046720B2Dimethylphosphine oxide compoundGUIZHOU INOCHINI TECH CO LTD·Filed 2019·Granted Jun 29, 2021·0 cites·12 claims
Join the waitlist — get patent alerts
Get an alert when Xiawei Wei files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →